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Abstract
Achieving high accuracy in the imaging of biological targets is a challenging issue. For MRI, to
enhance imaging accuracy, two different imaging modes with specific contrast agents are used;
one is T1 type for a “positive” MRI signal and the other is T2 type for a “negative” signal.
Conventional contrast agents response only in a single imaging mode and frequently encounter
ambiguities in the MR images. Here, we propose a “magnetically decoupled” core-shell design
concept to develop a dual mode nanoparticle contrast agent (DMCA). This DMCA not only
possesses superior MR contrast effects, but also has the unique capability of displaying “AND”
logic signals in both the T1 and T2 modes. The latter enables self-confirmation of images and
leads to a greater diagnostic accuracy. A variety of novel DMCAs are possible and the use of
DMCAs can potentially bring the accuracy of MR imaging of diseases to a higher level.
By combining complementary information obtained from various imaging methods,
including magnetic resonance imaging (MRI), positron emission tomography (PET),
computed tomography (CT) and optical microscopy, multi-modal imaging techniques have
been devised to increase the accuracy of disease diagnosis.1 However, even when multi-
modal techniques are employed, inherent problems still exist. For example, image matching
difficulties caused by relocating biological samples and the discrepancies resulting from
different depth penetrations and spatial/time resolutions of multiple imaging devices can
lead to inaccuracies.1a,b Therefore, the development of dual imaging strategies that employ a
single instrumental system is another important approach.
MRI is a powerful technique for tomographic images of biological targets in a non-invasive
manner with a high spatial resolution. In MRI, relaxation time of protons of water in the
sample is measured. Contrast agents are employed to greatly change proton relaxation rates
and to enhance visualization of the differences between normal and disease tissues. T1
contrast agents, comprised typically of paramagnetic materials such as Gd complexes and
Mn oxide nanoparticles, facilitate spin-lattice relaxation of protons causing a positive (or
bright) MR image.2,3 On the other hand, T2 contrast agents that commonly consist of
superparamagnetic nanoparticles (e.g. iron oxide) cause protons in their vicinity to undergo
spin-spin relaxation which gives rise to negative (or dark) MR images.3,4 Even so, such
single mode contrast agents are not yet perfect and increasingly facing challenges especially
when accurate imaging of small biological targets is needed.5
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A dual mode strategy for MRI, where two different T1 and T2 imaging modes are utilized
simultaneously, can potentially give highly sensitive and accurate information. For such
purposes, ultra small superparamagnetic iron oxide (USPIO), which displays enhanced T1
contrast effects, has been developed, but their T2 contrast effects are weak.6 Although a
system comprised of FeCo nanoparticles is the only one reported thus far that exhibits high
T1 and T2 contrast effects,7 an understanding of the mechanism by which this system
operates is still unclear. The difficulty associated with the design of well-defined T1 and T2
dual mode contrast agents is related in part to the fact that, in the case of their direct contact,
the magnetic field generated by a superparamagnetic T2 contrast material perturbs the
relaxation process of the paramagnetic T1 contrast material. This phenomenon results in the
quenching of the T1 signal (Figure 1a). Until now, a rational design of dual mode MRI
contrast agents has not been proposed.
In our studies described below, we have led to the design and construction of a new T1-T2
dual mode nanoparticle contrast agent (DMCA). Organic block copolymers that form
micellar structures, inorganic porous materials, such as MCM-48 that produce porous
structures, and inorganic materials that generate core-shell structures are potential
frameworks for construction of T1-T2 DMCAs (Figure 1b). Here, we selected T1-T2
DMCA that has inorganic core-shell structured particles, in which the T2 contrast material is
located in the core and the T1 contrast material is positioned on the shell. By inserting a
thickness-tunable separating layer, the magnetic coupling between the T1 and T2 materials
can be modulated so that conditions for simultaneous generation of strong T1 and T2
contrast effects can be found. The T1 contrast material is positioned on the shell of the
particles so that it is in direct contact with water.2a,8 On the other hand, the
superparamagnetic T2 contrast material is situated inside the core since it can produce a long
range magnetic field to promote the spin-spin relaxation process of surrounding water
molecules.8 In this system, 15 nm diameter MnFe2O4 was used as the core T2 contrast
material.4b T1 and T2 contrast materials were separated by a layer of SiO2 with thicknesses
of 4, 8, 12, 16 and 20 nm, formed by using a sol-gel reaction (Figure S1).9 Finally, the T1
contrast material, Gd2O(CO3)2 with a thickness of ca. 1.5 nm, was deposited on top of the
SiO2 layer by using Gd(NO3)3 as a precursor (Figure 2a and Figure S2 and S3).10 Figure 2b
are TEM images of the synthesized DMCA of MnFe2O4@SiO2@Gd2O(CO3)2. The contrast
effects of T1 weighted MR images of the DMCA show significant changes, which are
dependent on the thickness of the separating SiO2 layer. When the thickness of this layer is
small and, as a result, the T1 and T2 contrast materials are closely located (e.g. 4 nm),
almost no T1 contrast effect is observed. However, as the thickness of the separating layer
increases, the T1 contrast dramatically changes from dark gray to bright (Figure 2c, top).
Such change is clearly observed in the color coded MR image (Figure 2c, bottom). The
relaxivity coefficient, r1, which is the value of MR contrast effects, changes in the order of
2.0, 4.0, 25.1, 33.1 and 32.5 mM-1s-1 as the thickness of the separating layer increases in the
respective order of 4, 8, 12, 16 and 20 nm (Figure 2e and h). The largest change corresponds
to a 16 times increase of the T1 effect. When the thickness of the separating layer exceeds
12 nm, the DMCA shows a strong T1 signal, which is roughly 3 times larger than that of the
conventional contrast agent, Gd-DTPA (Gadolinium-diethylenetriaminepentaacetate,
Magnevist, r1 = 9.6 mM-1s-1). Higher r1 effect of DMCA is possibly caused by its slower
tumbling rate compared to molecular contrast agent.11 T1 signal is high when paramagnetic
electron spins of T1 contrast agent are directly in contact with water molecules via dipolar
interactions between electron spins of contrast agent and nuclear spins of water.2b,12 By
introducing T2 nanoparticle contrast agent, however, such coupling processes are perturbed
by additional magnetic field generated. As seen in this case, such effects are tunable by
using separating layer between T1 and T2 materials. By controlling the thickness of the
separating layer, quenching of the T1 signal by the T2 superparamagnetic core dramatically
decreases from 94% to 0 % (Figure 2f and Table S1). The T2 contrast gradually changes
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from black to dark gray as the thickness of SiO2 increases (Figure 2d). The T2 relaxivity
coefficient (r2) of the DMCA changes in the order of 332, 318, 305, 274 and 213 mM-1s-1
as the SiO2 thickness increases in the respective order of 4, 8, 12, 16 and 20 nm (Figure 2g
and h and Table S2). In our DMCA model, T2 nanoparticle contrast agent in the core is a
magnet which generates a new local magnetic field which is known to be distance-
dependent with 1/d3 (d = distance from the T2 agent).13 This magnetic field prompts
transverse T2 relaxation rate of water nuclear spins in the vicinity.12,14 However, the
presence of SiO2 layer reduces magnetic field to the surrounding water molecules, which
results in reduced T2 contrast effects with roughly 1/3 loss of T2 contrast effect in the case
of 20 nm SiO2 layer. Even so, all of the DMCAs still have at least two times higher r2
values compared to the conventional T2 agent, Feridex (iron oxide, r2 = 108 mM-1s-1). The
field dependent dipolar couplings are critical in T1 and T2 signals and it is observed that
electron spin relaxation processes of T1 agents are more susceptible to the attenuation of
local magnetic field.
The DMCA developed in this effort displays dual mode contrast effects and, therefore, it can
be used to perform AND logic in MR imaging. In the positive T1 mode, both the DMCA
and Gd-DTPA display bright MR signals with “ON” responses while water and Feridex
have dark T1 signals with “OFF” responses (Figure 3a). In the negative T2 mode, the
DMCA and Feridex display dark signals, which correspond to “ON” states while water and
Gd-DTPA show bright T2 signals, which are “OFF” states. Importantly, only the DMCA
possesses “ON” states in both imaging modes. Therefore, unlike conventional contrast
agents, the DMCA has AND logic, which gives the MR imaging a self-confirmation
capability. This feature was demonstrated by performing MR imaging with three separate 1
mm diameter tubings, each containing DMCA, Feridex and Gd-DTPA, which were
implanted in a mouse (Figure 3b). In specific, relaxivity change of each imaging mode (ΔRi/
Ripre-contrast, Ri = 1 / Ti; i = 1,2) were measured. Higher Ri indicates better contrast effects.
In T1 image, ROI #2 (Gd-DTPA) and ROI #3 (DMCA) exhibit large relaxivity change of 30
% and 35%, respectively. In T2 image, ROI #1 (Feridex) and ROI #3 (DMCA) exhibit high
relaxivity change of 35% and 72%, respectively. All the other ROIs give minimal signal
changes in both T1 and T2 image. Among all the ROIs examined, only DMCA shows
simultaneously high MR signals in both T1 and T2 mode. As a consequence of the ability to
change from bright to dark reversibly leading to “ON” state responses for AND logic, the
DMCA can be used to provide self-confirmed imaging. Any faulty “AND” logic can be
eliminated by comparing changes between pre-contrast and post-contrast MR images which
will render fault-free MRI capability.
Here, we have demonstrated core-shell design approach where the degree of T1 and T2
couplings can be modulated by using a separating layer, which makes it possible to create
new contrast agents with tunable and maximized T1 and T2 signals. Our DMCA has not
only a universal design concept for any T1/T2 combinations, but also adopts a synthetic
method which is simple and reproducible. The finding suggests that DMCA can be
potentially applied to the imaging of wide range of biological targets with enhance
diagnostic accuracy.
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Figure 1.
Magnetic coupling between T1 and T2 contrast materials and the structures for a dual mode
nanoparticle contrast agent (DMCA). (a) Electronic spins of paramagnetic T1 contrast
materials are affected by a magnetic field from superparamagnetic T2 contrast materials
when they are in close proximity. (b) Possible structure for a dual mode nanoparticle
contrast agent with separating layers to prevent magnetic coupling between them.
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Figure 2.
T1 and T2 MR imaging of DMCA with a separating layer of SiO2. (a) Schematic and
transmission electron microscope (TEM) image of core-shell type DMCA
[MnFe2O4@SiO2@Gd2O(CO3)2]. (b) TEM images of DMCA with variable separating layer
thickness (4, 8, 12, 16 and 20 nm), having a fixed MnFe2O4 core (15 nm in diameter) and a
Gd2O(CO3)2 shell (1.5 nm). (c) T1- and (d) T2-weighted MR images and their color coded
images of DMCA with various SiO2 thickness by using 4.7 T MRI. Contrast agents: 200 μM
(Gd) for T1 image, 100 μM (Mn+Fe) for T2 images. The images of Gd-DTPA and Feridex
were taken together for the comparison purpose. In the color coded image, positive and
negative contrasts were indicated by red and blue color, respectibly. (e) Graph of r1 vs. SiO2
thickness. (f) Graph of T1 quenching vs. SiO2 thickness [T1 quenching (%) =
{(r1SiO2@GdO2(CO3)2-r1DMCA)/r1SiO2@Gd2O(CO3)2}×100, r1SiO2@Gd2O(CO3)2 = 31 mM
-1s-1
(Table S1)]. (g) Graph of r2 vs. SiO2 thickness. (h) r1 and r2 of DMCA, MnFe2O4, Gd-
DTPA and Feridex.
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Figure 3.
DMCA as AND logic contrast agent. (a) T1- and T2-weighted MR images of DMCA
[MnFe2O4@SiO2@Gd2O(CO3)2, SiO2 = 16 nm], Feridex, Gd-DTPA and water. In T1
mode, positive (or bright) MR image was “ON” state, while negative (or dark) image was
“OFF” state. In T2 mode, dark image was “ON” state, while bright image was “OFF” state.
Only DMCA exhibited “ON” state in both T1- and T2-weighted images to give its AND
logic. (b) T1- and T2-weighted transverse MR images of a mouse where 1 mm diameter
tubings containing DMCA, Feridex and Gd-DTPA were implanted near abdomen. Changes
of relaxivity R1 and R2 (ΔRi/ Ripre-contrast (%) = (Ri − Ripre-contrast)/ Ripre-contrast; i=1,2)
were measured for eight different regions of interest (ROI) by comparing pre- and post-
contrast image. Higher Ri indicates enhanced contrast effects. In T1 image, ROI #2 (Gd-
DTPA) and ROI #3 (DMCA) exhibited relaxivity change of 30% and 35%. In T2 image,
ROI #1 (Feridex) and ROI #3 (DMCA) exhibited relaxivity change of 35% and 72%. All the
other ROIs exhibited minimal signals (∼5%) in both T1 and T2 image. Only DMCA
exhibited simultaneously high signal in both T1 and T2 to satisfy “ON” output for AND
logic. T1 images were obtained by using fat suppression sequence and all images were taken
by using 3 T MRI. Contrast agents: 200 μM (Gd) for T1 image, 100 μM (Fe) for T2 image.
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